RIVZEPRI

Serial Number 97274856
730

Registration Progress

Application Filed
Feb 18, 2022
Under Examination
Jan 2, 2024
Approved for Publication
Nov 7, 2023
Published for Opposition
Nov 7, 2023
Registered

Trademark Image

RIVZEPRI

Basic Information

Serial Number
97274856
Filing Date
February 18, 2022
Published for Opposition
November 7, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
730
Status Date
Jun 18, 2024
Application
Pending
Classes
005

Rights Holder

FibroGen, Inc.

03
Address
350 Bay Street, Suite 100 #6009
San Francisco, CA 94133

Ownership History

FibroGen, Inc.

Original Applicant
03
San Francisco, CA

FibroGen, Inc.

Owner at Publication
03
San Francisco, CA

Legal Representation

Attorney
Harold Milstein

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

23 events
Date Code Type Description
Oct 7, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 7, 2024 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 7, 2024 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jun 18, 2024 EXT1 S SOU EXTENSION 1 FILED
Jun 18, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 18, 2024 EX1G S SOU EXTENSION 1 GRANTED
Jun 18, 2024 EEXT I SOU TEAS EXTENSION RECEIVED
Jan 2, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 7, 2023 PUBO A PUBLISHED FOR OPPOSITION
Nov 7, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 18, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 2, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 23, 2023 RCSC S REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Feb 21, 2023 RCSC S REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Aug 17, 2022 GNSL F LETTER OF SUSPENSION E-MAILED
Aug 17, 2022 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Aug 17, 2022 CNSL R SUSPENSION LETTER WRITTEN
Aug 15, 2022 DOCK D ASSIGNED TO EXAMINER
Apr 15, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 15, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 15, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 24, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 22, 2022 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of chronic fibrotic and proliferative disorders; pharmaceutical preparations for the treatment of cancer, muscular dystrophy and idiopathic pulmonary fibrosis

Classification

International Classes
005